meglumine antimoniate has been researched along with bisabolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corpas-López, V; Díaz-Sáez, V; Gijón-Robles, P; López-Viota, J; López-Viota, M; Martín-Sánchez, J; Merino-Espinosa, G; Morillas-Mancilla, MJ; Morillas-Márquez, F; Navarro Moll, MC | 1 |
| Acedo-Sánchez, C; Corpas-López, V; Díaz-Sáez, V; Martín-Sánchez, J; Merino-Espinosa, G; Morillas-Márquez, F; Navarro-Moll, MC | 1 |
1 trial(s) available for meglumine antimoniate and bisabolol
| Article | Year |
|---|---|
Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Monocyclic Sesquiterpenes; Organometallic Compounds; Parasite Load; Sesquiterpenes; Treatment Outcome | 2018 |
1 other study(ies) available for meglumine antimoniate and bisabolol
| Article | Year |
|---|---|
Topical Treatment of Leishmania tropica Infection Using (-)-α-Bisabolol Ointment in a Hamster Model: Effectiveness and Safety Assessment.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Cricetinae; Cytochrome P-450 CYP2D6 Inhibitors; Disease Models, Animal; Injections, Intralesional; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Molecular Structure; Monocyclic Sesquiterpenes; Organometallic Compounds; Sesquiterpenes; Skin; Stereoisomerism | 2016 |